MedTrace Logo

Genetic Causes of Hypercholesterolaemia in the Emirati Population

NCT03597958 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-06-25

No results posted yet for this study

Summary

The scientific aims of the project are to understand the genetic basis of Familial Hypercholesterolaemia (FH) in the Emirati population and estimate the overall prevalence of the disease. In addition, a clinical aim of the project is to explore the effectiveness of screening the relatives of individuals affected by FH and other lipid disorders ("cascade" screening) within Emirati families.

Conditions

  • Familial Hypercholesterolemia

Interventions

GENETIC

Next generation sequencing (NGS)

NGS panel, whole exome / genome sequencing (WES/WGS), transcriptome analysis

Sponsors & Collaborators

  • Imperial College London Diabetes Centre

    lead OTHER

Principal Investigators

  • Maha Barakat, PhD FRCP · Imperial College London Diabetes Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-17
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597958 on ClinicalTrials.gov